Investor Relations Home

Company Overview

LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.

At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol “LIVN.”

LivaNova is a market leader with a workforce of more than 4,500 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries. LivaNova operates as three business franchises:

  • Cardiac Surgery: We are a global leader in cardiac surgery based on many factors, including our established leadership position in heart-lung machines and recognition as the world’s #1 cardiopulmonary bypass company. Our advanced solutions have made significant contributions to open-heart surgery outcomes for many patients. Notably, we offer the only sutureless valve for aortic surgery.
  • Neuromodulation: As pioneers of the VNS (Vagus Nerve Stimulation) Therapy® system, we continue to advance medical device solutions for people affected by treatment-resistant epilepsy, depression and heart failure.
  • Cardiac Rhythm Management: Reflecting our spirit of imagination and invention, we have a long history of designing cardiac rhythm management systems, including pacemakers and defibrillators, that enhance and extend lives.

At LivaNova, we serve health and improve lives. Day by day. Life by life.

$62.140.00 (0.00%)Exchange
NASDAQ GS
Volume
0
Data as of 08/22/17 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minute delayed.
Refresh quote

Download our Corporate Overview Brochure (PDF)

Pro forma revenues by geography 1

  • Europe
  • United States of America
  • Rest of the World

1) Rounded numbers based on full-year 2015 revenue.

Pro forma revenues by business 1

  • Cardiac Surgery
  • Cardiac Rhythm Management
  • Neuromodulation

1) Rounded numbers based on full-year 2015 revenue.